We assumed that the increase in nonfasting blood insulin levels in the HFD + L-NAME group was secondary to insulin resistance as a consequence of feeding-induced increased insulin secretory demand [34], while in the ADRQβ-004 vaccine group, improved insulin resistance showed a low level of blood insulin in the nonfasting state. The gene discussed is INS; the disease is Insulin resistance.